These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29783322)

  • 1. Advocacy in personalized medicine: a developing strength in a complex space.
    Miller I; Pothier K; Dunn M
    Per Med; 2010 Mar; 7(2):179-186. PubMed ID: 29783322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Personalized Medicine Coalition: goals and strategies.
    Abrahams E; Ginsburg GS; Silver M
    Am J Pharmacogenomics; 2005; 5(6):345-55. PubMed ID: 16336000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current and future state of companion diagnostics.
    Agarwal A; Ressler D; Snyder G
    Pharmgenomics Pers Med; 2015; 8():99-110. PubMed ID: 25897259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical industry perspectives on the business prospects for personalized medicine.
    Milne CP; Zuckerman R
    Per Med; 2011 Sep; 8(5):541-550. PubMed ID: 29793252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US FDA and personalized medicine: in vitro diagnostic regulatory perspective.
    Težak Ž; Kondratovich MV; Mansfield E
    Per Med; 2010 Sep; 7(5):517-530. PubMed ID: 29776248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do providers, payers and patients need from comparative effectiveness research on diagnostics? The case of HER2/Neu testing in breast cancer.
    Trosman JR; Weldon CB; Schink JC; Gradishar WJ; Benson AB
    J Comp Eff Res; 2013 Jul; 2(4):461-77. PubMed ID: 24236686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A coalition to drive personalized medicine forward.
    Munroe JB
    Per Med; 2004 Dec; 1(1):9-13. PubMed ID: 29793218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving forces behind the past and future emergence of personalized medicine.
    Steffen JA; Steffen JS
    J Pers Med; 2013 Jan; 3(1):14-22. PubMed ID: 25562408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reflections on market access for personalized medicine: recommendations for Europe.
    Payne K; Annemans L
    Value Health; 2013; 16(6 Suppl):S32-8. PubMed ID: 24034310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EU policies in personalized medicine-related technologies.
    Gaisser S; Vignola-Gagné E; Hüsing B; Enzing C; van der Valk T
    Per Med; 2009 Jan; 6(1):93-102. PubMed ID: 29783384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the codevelopment of companion diagnostics.
    Moore MW; Babu D; Cotter PD
    Per Med; 2012 Jul; 9(5):485-496. PubMed ID: 29768776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The faces of personalized medicine: a framework for understanding its meaning and scope.
    Redekop WK; Mladsi D
    Value Health; 2013; 16(6 Suppl):S4-9. PubMed ID: 24034312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Payers and the assessment of clinical utility for companion diagnostics.
    Quinn B
    Clin Pharmacol Ther; 2010 Dec; 88(6):751-4. PubMed ID: 21081944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation, reimbursement, and the long road of implementation of personalized medicine--a perspective from the United States.
    Frueh FW
    Value Health; 2013; 16(6 Suppl):S27-31. PubMed ID: 24034309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summary of DIA Workshop on Co-Development of Personalized Medicine and In Vitro Diagnostic Companion Devices.
    Kim LP; Stuart JN; Schultz D; Boiani JA
    Ther Innov Regul Sci; 2013 May; 47(3):294-298. PubMed ID: 30231425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Companion diagnostics: a regulatory perspective from the last 5 years of molecular companion diagnostic approvals.
    Roscoe DM; Hu YF; Philip R
    Expert Rev Mol Diagn; 2015; 15(7):869-80. PubMed ID: 26109316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conference Scene: Personalized Medicine in Europe.
    Greenberg T
    Per Med; 2011 May; 8(3):317-319. PubMed ID: 29783529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
    O'Donnell JC
    Value Health; 2013; 16(6 Suppl):S1-3. PubMed ID: 24034305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing value of innovative molecular diagnostic tests in the concept of predictive, preventive, and personalized medicine.
    Akhmetov I; Bubnov RV
    EPMA J; 2015; 6():19. PubMed ID: 26425215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.